2. Membrane Transporter/Ion Channel Anti-infection Neuronal Signaling GPCR/G Protein
  3. Sec61 HIV Flavivirus Neurotensin Receptor
  4. VGD020

VGD020 is a highly potent and selective Sec61 translocon inhibitor. VGD020 suppresses the expression of cell surface CD4 by inhibiting signal peptide-dependent co-translational ER translocation, interferes with the initiation of ER translocation of dengue virus polyprotein, and reduces the expression of Sortilin in breast cancer cells. VGD020 exhibits broad anti-flavivirus and anti-HIV activities. VGD020 can be used in research related to dengue virus infection, Zika virus infection, yellow fever virus infection, human immunodeficiency virus infection, and breast cancer.

For research use only. We do not sell to patients.

VGD020

VGD020 Chemical Structure

CAS No. : 1322645-32-8

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

VGD020 Related Antibodies

Top Publications Citing Use of Products

View All HIV Isoform Specific Products:

View All Isoforms
HIV HIV-1 HIV-2

View All Neurotensin Receptor Isoform Specific Products:

View All Isoforms
NTR1 NTR2

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

VGD020 is a highly potent and selective Sec61 translocon inhibitor. VGD020 suppresses the expression of cell surface CD4 by inhibiting signal peptide-dependent co-translational ER translocation, interferes with the initiation of ER translocation of dengue virus polyprotein, and reduces the expression of Sortilin in breast cancer cells. VGD020 exhibits broad anti-flavivirus and anti-HIV activities. VGD020 can be used in research related to dengue virus infection, Zika virus infection, yellow fever virus infection, human immunodeficiency virus infection, and breast cancer[1][2][3].

In Vitro

VGD020 (0.01-10 μM; 4-5 days) potently inhibits DENV2 replication in Vero cells, and achieves complete antiviral activity at micromolar concentrations[1].
VGD020 (0.01-100 μM; 4-5 days) exhibits low cytotoxicity in Vero cells, with minimal effects on cell viability even at concentrations as high as 100 μM[1].
VGD020 (0.01-10 μM; 4-5 days) potently inhibits DENV2 replication in Huh7 cells, and achieves complete antiviral activity at micromolar concentrations[1].
VGD020 (0.02-2 μM; 48 h) inhibits the expression of viral E protein in Huh7 cells infected with dengue virus type 2 (DENV2), and complete inhibition is achieved at a concentration of 0.4 μM after 48 h[1].
VGD020 (2 μM; 72 h) potently inhibits the expression of viral E protein in Huh7 cells infected with dengue virus type 2 (DENV2)[1].
VGD020 (1 μM; 0-24 h) exerts antiviral effects against DENV2 in Vero cells at the post-entry stage, and retains full activity even when added 8 h post-infection[1].
VGD020 (0.4-10 μM; 18 h) inhibits the expression of DENV2 prM and E proteins in transiently transfected HEK293T cells in a concentration-dependent manner, and its potency is consistent with its antiviral activity[1].
VGD020 (0.4-10 μM; 18 h) does not inhibit the expression of DENV2 NS1 protein in transiently transfected HEK293T cells even at concentrations as high as 10 μM[1].
VGD020 (0.4-10 μM; 18 h) selectively inhibits the expression of DENV2 prM protein, but does not inhibit the expression of E protein, in transiently transfected HEK293T cells[1].
VGD020 (0.15-15 μM) selectively inhibits Sec61-mediated co-translational translocation of DENV2 prM protein into the ER lumen in cell-free assays, with no effect on protein translation[1].
VGD020 (0.15-15 μM) does not inhibit Sec61-mediated co-translational translocation of truncated DENV2 E protein into the ER lumen in cell-free assays[1].
VGD020 (0.4-10 μM; 18 h) induces inhibition of DENV2 polyprotein trafficking, which in turn leads to proteasomal degradation of the precursor; co-treatment with MG132 partially reverses this effect in CHO-K1 cells[1].
VGD020 (0.01-10 μM; 18 h) potently inhibits the expression of 14C-prM62-VSV-G chimeric protein in HEK293T cells, with an IC50 of 308 nM[1].
VGD020 (0.01-10 μM; 18 h) does not inhibit the expression of M21-E62-VSV-G or E23-NS162-VSV-G chimeric proteins in HEK293T cells even at concentrations as high as 10 μM[1].
VGD020 (0.01-10 μM; 18 h) potently inhibits the expression of chimeric proteins containing the DENV2 C14 signal peptide sequence (the major determinant of sensitivity to VGD020), with an IC50 of 41 nM in HEK293T cells[1].
VGD020 (0.01-10 μM; 18 h) potently inhibits the expression of chimeric proteins containing C14 signal peptide sequences from multiple flaviviruses (DENV1, DENV3, DENV4, ZIKV) in HEK293T cells, with its IC50 value stably maintained at approximately 100 nM[1].
VGD020 (18 h) downregulates the expression of sortilin in HEK293T cells in a dose-dependent manner, with an IC50 of 0.5 μM[2].
VGD020 (24 h) potently downregulates CD4 expression in CHO CD4-YFP cells, with an IC50 of 46 nM[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

VGD020 Related Antibodies

Western Blot Analysis[1]

Cell Line: DENV2-infected Huh7 cells
Concentration: 0.02, 0.08, 0.4 and 2 μM
Incubation Time: 48 h
Result: Completely suppressed cellular expression of viral E protein at 0.4 μM.
Showed partial inhibition of viral E protein expression at lower concentrations relative to untreated infected controls.

Western Blot Analysis[1]

Cell Line: transiently transfected HEK293T cells (with plasmid encoding DENV2 C14-prM-E)
Concentration: 0.4, 2 and 10 μM
Incubation Time: 18 h
Result: Concentration-dependently inhibited expression of both prM and E proteins.
Achieved significant suppression at all tested concentrations relative to untreated transfected controls.

Western Blot Analysis[1]

Cell Line: transiently transfected HEK293T cells (with plasmid encoding DENV2 E23-NS1-V5)
Concentration: 0.4, 2 and 10 μM
Incubation Time: 18 h
Result: Had no inhibitory effect on NS1 protein expression at concentrations up to 10 μM.
Resulted in NS1 expression levels comparable to untreated transfected controls.

Western Blot Analysis[1]

Cell Line: transiently transfected HEK293T cells (with plasmids encoding either DENV2 M21-E or C14-prM)
Concentration: 0.4, 2 and 10 μM
Incubation Time: 18 h
Result: Concentration-dependently inhibited prM protein expression, with significant suppression at 2 and 10 μM.
Had no inhibitory effect on E protein expression at any tested concentration.

Western Blot Analysis[1]

Cell Line: transiently transfected CHO-K1 cells (with plasmid encoding DENV2 C14-prM-E_V5/FLAG/MYC)
Concentration: 0.4, 2 and 10 μM (alone or with 200 nM MG132)
Incubation Time: 18 h
Result: Rescued a small amount of the uncleaved prM-E polyprotein precursor (75 kDa) when combined with MG132, which was not detected in VGD020-only or untreated samples.
Resulted in non-glycosylated precursor in combination treatment samples.
Molecular Weight

603.84

Formula

C31H45N3O5S2
CAS No.
SMILES

O=S(C1=CC=C(C=C1)OC)(N2CC(CN(S(=O)(C3=CC=C(C)C=C3)=O)CCCN(CC4CCCCC4)CCC2)=C)=O
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

VGD020 Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

VGD0201322645-32-8VGD 020VGD-020Sec61HIVFlavivirusNeurotensin ReceptorSec61 complex, SecY, Sec61 channel Human immunodeficiency viruszika virusCD4CHO-K1 cellsVero cellsSec61αHEK293T cellsyellow fever virusdengue virusbreast cancer stem cellHuh7 cellsInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
VGD020
Cat. No.:
HY-182674
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.